SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-11-024138
Filing Date
2011-03-10
Accepted
2011-03-10 16:19:02
Documents
9
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K c13844e10vk.htm 10-K 922948
2 EXHIBIT 21.1 c13844exv21w1.htm EX-21.1 798
3 EXHIBIT 23.1 c13844exv23w1.htm EX-23.1 7150
4 EXHIBIT 31.1 c13844exv31w1.htm EX-31.1 5944
5 EXHIBIT 31.2 c13844exv31w2.htm EX-31.2 6253
6 EXHIBIT 32.1 c13844exv32w1.htm EX-32.1 2771
7 EXHIBIT 32.2 c13844exv32w2.htm EX-32.2 2830
8 GRAPHIC c13844c1384401.gif GRAPHIC 9743
9 GRAPHIC c13844c1384402.gif GRAPHIC 30695
  Complete submission text file 0000950123-11-024138.txt   1005807
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 033-80623 | Film No.: 11678710
SIC: 2835 In Vitro & In Vivo Diagnostic Substances